Michael P. Ludwig

Statistics

Publications

Citations

719

H-Index

Active since

2018

Affiliations

University of Colorado Anschutz Medical Campus(Current)

University of Colorado Denver

University of Colorado Boulder

National Jewish Health

University of Missouri–Kansas City

Michael P. Ludwig is an author at University of Colorado Anschutz Medical Campus specializing in life sciences, interferon responses, and immune dysregulation.

ORCID

Publications per year

2018–2023

Publications

Autophagy Inhibition Mediates Apoptosis Sensitization in Cancer Therapy by Relieving FOXO3a Turnover

Brent E. Fitzwalter, Christina G. Towers, Kelly D. Sullivan et al. · Developmental Cell · 2018 · 206 citations · Full text

Life Sciences, Cell Biology, Oncology +16

Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors

Rani K. Powers, Rachel Culp‐Hill, Michael P. Ludwig et al. · Nature Communications · 2019 · 146 citations · Full text

Life Sciences, Immunology, Molecular Genetics +17

Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model

Katherine A. Waugh, Ross Minter, Jessica Baxter et al. · Nature Genetics · 2023 · 112 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition

Matthew D. Galbraith, Angela L. Rachubinski, Keith P. Smith et al. · Science Advances · 2023 · 83 citations · Full text

Life Sciences, Genetics, Immunology +17

JAK1 Inhibition Blocks Lethal Immune Hypersensitivity in a Mouse Model of Down Syndrome

Kathryn D. Tuttle, Katherine A. Waugh, Paula Araya et al. · Cell Reports · 2020 · 66 citations · Full text

Life Sciences, Genetics, Immunology +17

1–5 of 9